PDS Biotechnology Corporation

8-K Delisting notice or listing-rule failure Jul 31, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity; Modified rights of security holders Jun 15, 2026 8-K Other events Jun 15, 2026 8-K Other events Jun 2, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 13, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity May 1, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 28, 2026 8-K Other events Apr 24, 2026 8-K Other events Apr 15, 2026 10-K Fiscal year ended 2025-12-31 Mar 30, 2026 8-K Results of operations (earnings release) Mar 30, 2026 8-K Delisting notice or listing-rule failure Mar 3, 2026 8-K Other events Feb 23, 2026 8-K Other events Feb 20, 2026 8-K Other events Jan 28, 2026 8-K Other events Jan 22, 2026 8-K Other events Jan 9, 2026 8-K Other events Dec 9, 2025 8-K Other events Dec 2, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Entered a material agreement; Results of operations (earnings release); Regulation FD disclosure; Other events Nov 12, 2025 8-K Other events Nov 10, 2025 8-K Other events Oct 29, 2025 8-K Other events Sep 18, 2025 8-K Other events Aug 25, 2025 8-K Other events Aug 25, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 13, 2025 8-K Other events Jul 10, 2025 8-K Other events Jun 25, 2025 8-K Director or officer change; Shareholder vote results Jun 11, 2025 8-K Other events Jun 2, 2025 8-K Other events May 22, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 8-K Other events May 8, 2025 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Unregistered sale of equity May 2, 2025 8-K Director or officer change Apr 24, 2025